Company · CIK 0001636651 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Ovid Therapeutics Inc. · OVID
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 AForm 4 → | Jul 8, 4:31 pm EDT | Charles Ross CarterChief Financial Officer | 50,000 | — | — | 94,375 | — | |
| Feb 26, 2019 PForm 4 → | Feb 28, 8:15 pm EST | Karen BernsteinDirector | 10,000 | $2.02 | $20,210 | 20,000 | +100% | plan? |
| Feb 22, 2019 PForm 4 → | Feb 26, 9:42 pm EST | Jeremy M LevinCEO, Director, 10% Owner | 75,000 | $2.00 | $150,000 | 4,676,529 | +1.63% | plan? |
| Aug 14, 2018 PForm 4 → | Aug 16, 9:24 pm EDT | Karen BernsteinDirector | 10,000 | $6.23 | $62,300 | 10,000 | — | plan? |
| Aug 14, 2018 PForm 4 → | Aug 16, 9:22 pm EDT | Douglas E WilliamsDirector | 5,000 | $6.49 | $32,442 | 5,000 | — | plan? |
| Aug 25, 2017 PForm 4 → | Aug 28, 6:29 pm EDT | Jeremy M LevinCEO, Director, 10% Owner | 15,334 | $7.15 | $109,638 | 4,601,529 | +0.33% | plan? |
| May 10, 2017 CForm 4 → | May 10, 5:16 pm EDT | Jeremy M LevinCEO, Director, 10% Owner | 435,611 | — | — | 35,461 | — | plan? |
| May 10, 2017 CForm 4 → | May 10, 5:14 pm EDT | Matthew DuringPresident and CSO, Director, 10% Owner | 28,245 | — | — | 4,307,314 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 AForm 4 → | Jun 17, 4:22 pm EDT | Anna GrekaDirector | 130,000 | — | — | 130,000 | — | |
| Feb 24, 2019 AForm 4 → | Feb 26, 9:56 pm EST | Amit RakhitCMO and PMO | 125,000 | — | — | 125,000 | — | |
| Feb 24, 2019 AForm 4 → | Feb 26, 9:54 pm EST | Timothy DalySVP,Finance & Corp. Controller | 50,000 | — | — | 50,000 | — | |
| Feb 24, 2019 AForm 4 → | Feb 26, 9:44 pm EST | Ana WardSVP and General Counsel | 40,000 | — | — | 40,000 | — | |
| Feb 24, 2019 AForm 4 → | Feb 26, 9:43 pm EST | Dirk HaasnerSVP, Global Regulatory Affairs | 75,000 | — | — | 75,000 | — | |
| Feb 24, 2019 AForm 4 → | Feb 26, 9:42 pm EST | Jeremy M LevinCEO, Director, 10% Owner | 250,000 | — | — | 250,000 | — | |
| Feb 24, 2019 AForm 4 → | Feb 26, 9:42 pm EST | Matthew DuringPresident and CSO, Director, 10% Owner | 70,000 | — | — | 70,000 | — | |
| Aug 27, 2018 AForm 4 → | Aug 29, 6:28 pm EDT | Ana WardSVP and General Counsel | 11,250 | — | — | 11,250 | — | |
| Aug 27, 2018 AForm 4 → | Aug 29, 6:27 pm EDT | Timothy DalySVP,Finance & Corp. Controller | 11,250 | — | — | 11,250 | — | |
| Aug 27, 2018 AForm 4 → | Aug 29, 6:26 pm EDT | Amit RakhitCMO and PMO | 70,000 | — | — | 70,000 | — | |
| Aug 27, 2018 AForm 4 → | Aug 29, 6:24 pm EDT | Dirk HaasnerSVP, Global Regulatory Affairs | 22,500 | — | — | 22,500 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 5:45 pm EDT | Douglas E WilliamsDirector | 5,813 | — | — | 5,813 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 5:43 pm EDT | Bart FriedmanDirector | 5,813 | — | — | 5,813 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 5:41 pm EDT | Barbara Gayle DuncanDirector | 5,813 | — | — | 5,813 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 5:40 pm EDT | Karen BernsteinDirector | 5,813 | — | — | 5,813 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 4:47 pm EST | Yaron WerberCBO, CFO, Sec. and Treas. | 131,000 | — | — | 131,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 4:45 pm EST | Ana WardSVP and General Counsel | 20,000 | — | — | 20,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 4:43 pm EST | Amit RakhitCMO and PMO | 95,000 | — | — | 95,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 4:41 pm EST | Jeremy M LevinCEO, Director, 10% Owner | 290,000 | — | — | 290,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 4:40 pm EST | Dirk HaasnerSVP, Global Regulatory Affairs | 30,000 | — | — | 30,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 4:39 pm EST | Matthew DuringPresident and CSO, Director, 10% Owner | 110,000 | — | — | 110,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 4:37 pm EST | Timothy DalySVP,Finance & Corp. Controller | 30,000 | — | — | 30,000 | — | |
| Sep 5, 2017 AForm 4 → | Sep 6, 6:23 pm EDT | Ana WardSVP and General Counsel | 95,000 | — | — | 95,000 | — | |
| Jun 14, 2017 AForm 4 → | Jun 15, 5:51 pm EDT | Barbara Gayle DuncanDirector | 11,627 | — | — | 11,627 | — | |
| May 10, 2017 AForm 4 → | May 10, 5:17 pm EDT | Yaron WerberCBO, CFO, Sec. and Treas. | 93,022 | — | — | 93,022 | — | |
| May 10, 2017 CForm 4 → | May 10, 5:16 pm EDT | Jeremy M LevinCEO, Director, 10% Owner | 435,611 | — | — | 0 | — | |
| May 10, 2017 CForm 4 → | May 10, 5:14 pm EDT | Matthew DuringPresident and CSO, Director, 10% Owner | 28,245 | — | — | 0 | — | |
| May 10, 2017 AForm 4 → | May 10, 5:13 pm EDT | Timothy DalyVP, Finance & Corp. Controller | 46,510 | — | — | 46,510 | — |